High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors

Cell Biochemistry and Function

Volumn 15, Issue 3, 1997, Pages 197-201

  Hehenberger, Karin ^a   Hansson, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

(G)lucose; Antioxidants; Fibroblasts; Growth factors; Protein kinase C inhibitors

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BISINDOLYLMALEIMIDE; DIMETHYLTHIOUREA; EPIDERMAL GROWTH FACTOR; GLUCOSE; GROWTH FACTOR; PROTEIN KINASE C INHIBITOR; SELENITE; SOMATOMEDIN; TROGLITAZONE;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC FOOT; DNA CONTENT; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; FLUOROMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WOUND HEALING;

EID: 0030875938     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-0844(199709)15:3<197::aid-cbf740>3.0.co;2-7     Document Type: Article

References (21)

1. Eriksson, J., Franssila-Kallunki, A., Ekstrand, A , Saloranta, C , Widen, E., Schalin, C. and Groop, L. (1989). Early metabolic defects in persons at risk for NIDDM. N. Engl. J. Med., 321, 337-343.
2. Yki-Jarvinen, H. and Koivisto, V. A. (1984). Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J. Endocrinol. Metab, 58, 659-666.
3. Rossetti, L., Smith, D., Schulman, G. I., Papachristou, D. and DeFronzo, R. A. (1987). Correction of hyperglycaemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest., 79, 1510-1515.
4. Takayama, S., White, M. F. and Kahn, C. R. (1988). Phorbol ester-induced senne phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J. Biol. Chem., 263, 3440-3447.
5. Muller, H. K., Kellerer, M., Ermel, B., Muhlhofer, A., Obermaier-Kusser, B., Vogt, B and Haring, H. U. (1991). Prevention by PKC inhibitors of glucose-induced insulin receptor tyrosine kinase resistance in rat fat cells. Diabetes, 40, 1440-1448.
6. DeFronzo, R. A., Bonadonna, R. C. and Ferrannini, E. (1992). Pathogenesis of NIDDM. A balanced review. Diabetes Care, 15, 318-368.
7. Kirsch, D. M., Bachman, W. and Haring, H. U. (1984). Ciglitazone reverses cAMP induced post-insulin receptor resistance in rat adipocytes in vitro. FEBS Lett., 76, 49-54.
8. Iwamoto, Y., Kuzuya, T., Matsuda, A., Awata, T., Kumakura, S., Inooka, G. and Shiraishi, I. (1991). Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.
9. Rao, J and Otto, W. R. (1992). Fluorometric DNA assay for cell growth estimation. Anal. Biochem., 207, 186-192.
10. Curcio, F. and Ceriello, A. (1992). Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanism of diabetic complications. In Vitro Cell Develop., 28A, 787-790.
11. Pfeiffer, A. and Schatz, H. (1995). Diabetic microvascular complications and growth factors. Exp. Clin. End. Diab., 103, 7-14
12. Lorenzi, M., Nordberg, J. A. and Toledo, S. (1987). High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes, 36, 1261-1267.
13. Kahn, C. R. (1980). Role of insulin receptor in insulin resistant states. Met. Clin. Exp., 29, 455-466.
14. Kellerer, M., Kroder, G., Tippmer, S., Berti, L., Kiehn, R., Morthaf, L. and Haring, H. (1994). Troglitazone prevents glucose-induced insulin resistance of inuslin receptor in rat-1 fibroblasts. Diabetes, 43, 447-453.
15. Maegawa, H., Ide, R , Hasegawa, M., Ugi, S., Egawa, K., Iwanishi, M., Kikkawa, R., Shigeta, Y. and Kashiwagi, A. (1995). Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of PTPase activities. J. Biol. Chem., 270, 7724-7730.
16. The Diabetes Control and Complications Trial Research Group (1993). N. Engl. J. Med., 329, 977-986.
17. Kunisaki, M., Bursell, S. E., Umeda, F., Nawata, H. and King, G. (1994). Normalization of DAG-PKC activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes, 43, 1372-1377.
18. Porte, D and Schwartz, M. (1996), Diabetes complications: Why is glucose potentially toxic? Science, 272, 699-700.
19. Kunisaki, M., Bursell, S E., Clermont, A. C., Ishii, H., Ballas, L. M., Jirousek, M. R., Umeda, F., Nawata, H. and King, G. L. (1995) Vitamin E prevents diabetes induced abnormal retinal blood flow via the DAG-PKC pathway. Am. J. Physiol., 269, 239-246.
20. Berti, L., Mosthaf, L., Kroder, G., Kellerer, M , Tippmer, S., Muschack, J., Seffer, E., Seedorf, K. and Haring, H. (1994) Glucose-induced translocation of PKC isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J. Biol. Sci., 269, 3381-3386.
21. Jain, S K., Levine, S. N , Duett, J. and Hollier, B. (1991). Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes, 40, 1241-1244.